Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05964829 · ClinicalTrials.gov registry record · NA

Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis

A NA study of Multiple Sclerosis and Multiple Sclerosis (Relapsing Remitting), sponsored by Cionic.

Recruiting
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT05964829 is a NA study of Multiple Sclerosis and Multiple Sclerosis (Relapsing Remitting) that is actively recruiting participants, run by Cionic. The registered enrollment target is 14 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05964829, a NA study of Multiple Sclerosis and Multiple Sclerosis (Relapsing Remitting), is actively recruiting participants, sponsored by Cionic.

RECRUITING
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to support the clinical value of the Cionic Neural Sleeve for individuals diagnosed with multiple sclerosis (MS).

Interventions

  • DEVICE Cionic Neural Sleeve NS-100
  • BEHAVIORAL Walking Program

Study Locations (1)

Ohio

  • Cleveland State University - Cleveland

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2023-09-04
Est. Completion 2026-07
Phase NA

Sponsor

Cionic

5 total trials

What the Registry Record Tells You About NCT05964829

The ClinicalTrials.gov registry entry for NCT05964829 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (98% lower). The listed sponsor is Cionic, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Cionic Neural Sleeve NS-100 is the first listed.

NCT05964829 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05964829 about?

NCT05964829 is a clinical study titled "Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis". The purpose of this research is to support the clinical value of the Cionic Neural Sleeve for individuals diagnosed with multiple sclerosis (MS).

What is the current status of trial NCT05964829?

This trial is currently recruiting. It is a NA study. The enrollment target is 14 participants. The study started on 2023-09-04. Estimated completion is 2026-07.

What conditions does trial NCT05964829 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Multiple Sclerosis (Relapsing Remitting), Multiple Sclerosis, Chronic Progressive.

What interventions are being tested in trial NCT05964829?

The interventions under investigation include: Cionic Neural Sleeve NS-100 (DEVICE), Walking Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT05964829?

This trial is sponsored by Cionic, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05964829 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.